| Year |
Citation |
Score |
| 2023 |
Arellano G, Loda E, Chen Y, Neef T, Cogswell AC, Primer G, Joy G, Kaschke K, Wills S, Podojil JR, Popko B, Balabanov R, Miller SD. Interferon-γ controls aquaporin-4-specific Th17 and B cells in neuromyelitis optica spectrum disorder. Brain : a Journal of Neurology. PMID 37931066 DOI: 10.1093/brain/awad373 |
0.363 |
|
| 2022 |
Titus HE, Xu H, Robinson AP, Patel PA, Chen Y, Fantini D, Eaton V, Karl M, Garrison ED, Rose IVL, Chiang MY, Podojil JR, Balabanov R, Liddelow SA, Miller RH, ... ... Miller SD, et al. Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis. Glia. PMID 35809238 DOI: 10.1002/glia.24231 |
0.309 |
|
| 2022 |
Podojil JR, Genardi S, Chiang MY, Kakade S, Neef T, Murthy T, Boyne MT, Elhofy A, Miller SD. Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 35725270 DOI: 10.4049/jimmunol.2200208 |
0.36 |
|
| 2021 |
Loda E, Arellano G, Perez-Giraldo G, Miller SD, Balabanov R. Can Immune Tolerance Be Re-established in Neuromyelitis Optica? Frontiers in Neurology. 12: 783304. PMID 34987468 DOI: 10.3389/fneur.2021.783304 |
0.324 |
|
| 2021 |
Neef T, Ifergan I, Beddow S, Penaloza-MacMaster P, Haskins K, Shea LD, Podojil JR, Miller SD. Tolerance Induced by Antigen-Loaded PLG Nanoparticles Affects the Phenotype and Trafficking of Transgenic CD4 and CD8 T Cells. Cells. 10. PMID 34943952 DOI: 10.3390/cells10123445 |
0.336 |
|
| 2021 |
Qian Y, Arellano G, Ifergan I, Lin J, Snowden C, Kim T, Thomas JJ, Law C, Guan T, Balabanov RD, Kaech SM, Miller SD, Choi J. ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis. Cell Reports. 36: 109602. PMID 34433042 DOI: 10.1016/j.celrep.2021.109602 |
0.358 |
|
| 2021 |
Neef T, Miller SD. Novel delivery mechanisms for antigen-specific immunotherapy. Current Opinion in Endocrinology, Diabetes, and Obesity. PMID 34101653 DOI: 10.1097/MED.0000000000000649 |
0.319 |
|
| 2020 |
Podojil JR, Ifergan I, Chiang MY, Meeks JJ, Miller SD. Methodology for Assessment of Human T Cell Activation and Blockade. Bio-Protocol. 10: e3644. PMID 33659314 DOI: 10.21769/BioProtoc.3644 |
0.32 |
|
| 2020 |
Titus HE, Chen Y, Podojil JR, Robinson AP, Balabanov R, Popko B, Miller SD. Pre-clinical and Clinical Implications of "Inside-Out" vs. "Outside-In" Paradigms in Multiple Sclerosis Etiopathogenesis. Frontiers in Cellular Neuroscience. 14: 599717. PMID 33192332 DOI: 10.3389/fncel.2020.599717 |
0.32 |
|
| 2020 |
Morris AH, Hughes KR, Oakes RS, Cai MM, Miller SD, Irani DN, Shea LD. Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis. Nature Communications. 11: 3871. PMID 32747712 DOI: 10.1038/S41467-020-17629-Z |
0.303 |
|
| 2020 |
Park SJ, Riccio RE, Kopp SJ, Ifergan I, Miller SD, Longnecker R. Herpesvirus Entry Mediator Binding Partners Mediate Immunopathogenesis of Ocular Herpes Simplex Virus 1 Infection. Mbio. 11. PMID 32398314 DOI: 10.1128/Mbio.00790-20 |
0.383 |
|
| 2020 |
Freitag TL, Podojil JR, Pearson RM, Fokta FJ, Sahl C, Messing M, Andersson LC, Leskinen K, Saavalainen P, Hoover LI, Huang K, Phippard D, Maleki S, King NJC, Shea LD, ... Miller SD, et al. Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease. Gastroenterology. PMID 32032584 DOI: 10.1053/J.Gastro.2020.01.045 |
0.31 |
|
| 2020 |
Kelly CP, Murray JA, Leffler D, Bledsoe AC, Smithson G, Podojil J, First R, Morris A, Boyne M, Elhofy A, Wu T, Miller S. 630 TAK-101 (TIMP-GLIA) PREVENTS GLUTEN CHALLENGE INDUCED IMMUNE ACTIVATION IN ADULTS WITH CELIAC DISEASE Gastroenterology. 158: S-135. DOI: 10.1016/S0016-5085(20)31017-9 |
0.381 |
|
| 2019 |
Saito E, Kuo R, Kramer KR, Gohel N, Giles DA, Moore BB, Miller SD, Shea LD. Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease. Biomaterials. 222: 119432. PMID 31480002 DOI: 10.1016/J.Biomaterials.2019.119432 |
0.318 |
|
| 2019 |
Jamison BL, Neef T, Goodspeed A, Bradley B, Baker RL, Miller SD, Haskins K. Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 31109955 DOI: 10.4049/Jimmunol.1900127 |
0.309 |
|
| 2019 |
Chen Y, Podojil JR, Kunjamma RB, Jones J, Weiner M, Lin W, Miller SD, Popko B. Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis. Brain : a Journal of Neurology. PMID 30657878 DOI: 10.1093/Brain/Awy322 |
0.301 |
|
| 2019 |
Galvin JP, Beddow SA, Miller S. The Therapeutic Effect of Immune-Modifying Microparticles in an Acute Graft-Versus-Host Disease Model Biology of Blood and Marrow Transplantation. 25: S298-S300. DOI: 10.1016/J.Bbmt.2018.12.679 |
0.373 |
|
| 2018 |
Pearson RM, Podojil JR, Shea LD, King NJ, Miller SD, Getts DR. OVERCOMING CHALLENGES IN TREATING AUTOIMMUNTITY: DEVELOPMENT OF tolerogenic immune-modifying nanoparticles. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30352312 DOI: 10.1016/J.Nano.2018.10.001 |
0.376 |
|
| 2018 |
Smarr CB, Miller SD. The Use of Biodegradable Nanoparticles for Tolerogenic Therapy of Allergic Inflammation. Methods in Molecular Biology (Clifton, N.J.). 1799: 353-358. PMID 29956163 DOI: 10.1007/978-1-4939-7896-0_25 |
0.791 |
|
| 2018 |
Xu D, Robinson AP, Ishii T, Duncan DS, Alden TD, Goings GE, Ifergan I, Podojil JR, Penaloza-MacMaster P, Kearney JA, Swanson GT, Miller SD, Koh S. Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy. The Journal of Experimental Medicine. PMID 29487082 DOI: 10.1084/Jem.20171285 |
0.72 |
|
| 2018 |
Hecht I, Toporik A, Podojil JR, Vaknin I, Cojocaru G, Oren A, Aizman E, Liang SC, Leung L, Dicken Y, Novik A, Marbach-Bar N, Elmesmari A, Tange C, Gilmour A, ... ... Miller SD, et al. ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 29431694 DOI: 10.4049/jimmunol.1700325 |
0.36 |
|
| 2018 |
Podojil JR, Hecht I, Chiang MY, Vaknin I, Barbiro I, Novik A, Neria E, Rotman G, Miller SD. ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance. Journal of Immunology (Baltimore, Md. : 1950). PMID 29431690 DOI: 10.4049/jimmunol.1700326 |
0.343 |
|
| 2018 |
Galvin JP, Beddow SA, Miller S. The Therapeutic Effect of Immune-Modifying Microparticles in Acute Graft-Versus-Host Disease Blood. 132: 5671-5671. DOI: 10.1182/Blood-2018-99-120382 |
0.42 |
|
| 2017 |
Prasad S, Neef T, Xu D, Podojil JR, Getts DR, Shea LD, Miller SD. Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells. Journal of Autoimmunity. PMID 29258717 DOI: 10.1016/J.Jaut.2017.12.010 |
0.353 |
|
| 2017 |
O'Hagan KL, Miller SD, Phee H. Pak2 is essential for the function of Foxp3+ regulatory T cells through maintaining a suppressive Treg phenotype. Scientific Reports. 7: 17097. PMID 29213081 DOI: 10.1038/s41598-017-17078-7 |
0.34 |
|
| 2017 |
Jeong SJ, Cooper JG, Ifergan I, McGuire TL, Xu D, Hunter Z, Sharma S, McCarthy D, Miller SD, Kessler JA. Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice. Neurobiology of Disease. PMID 28823935 DOI: 10.1016/J.Nbd.2017.08.006 |
0.614 |
|
| 2017 |
Ifergan I, Davidson TS, Kebir H, Xu D, Palacios-Macapagal D, Cann J, Rodgers JM, Hunter ZN, Pittet CL, Beddow S, Jones CA, Prat A, Sleeman MA, Miller SD. Targeting the GM-CSF receptor for the treatment of CNS autoimmunity. Journal of Autoimmunity. PMID 28641926 DOI: 10.1016/J.Jaut.2017.06.005 |
0.669 |
|
| 2017 |
Kuo R, Saito E, Miller SD, Shea LD. Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28408181 DOI: 10.1016/J.Ymthe.2017.03.032 |
0.356 |
|
| 2016 |
McCarthy DP, Yap JW, Harp CT, Song WK, Chen J, Pearson RM, Miller SD, Shea LD. An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27720992 DOI: 10.1016/J.Nano.2016.09.007 |
0.669 |
|
| 2016 |
Smarr CB, Yap WT, Neef TP, Pearson RM, Hunter ZN, Ifergan I, Getts DR, Bryce PJ, Shea LD, Miller SD. Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization. Proceedings of the National Academy of Sciences of the United States of America. PMID 27091976 DOI: 10.1073/Pnas.1505782113 |
0.809 |
|
| 2016 |
Luo X, Miller SD, Shea LD. Immune Tolerance for Autoimmune Disease and Cell Transplantation. Annual Review of Biomedical Engineering. PMID 26928211 DOI: 10.1146/Annurev-Bioeng-110315-020137 |
0.314 |
|
| 2016 |
Winger RC, Harp CT, Chiang MY, Sullivan DP, Watson RL, Weber EW, Podojil JR, Miller SD, Muller WA. Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease. Journal of Immunology (Baltimore, Md. : 1950). PMID 26773145 DOI: 10.4049/Jimmunol.1501634 |
0.353 |
|
| 2015 |
Traka M, Podojil JR, McCarthy DP, Miller SD, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nature Neuroscience. PMID 26656646 DOI: 10.1038/Nn.4193 |
0.723 |
|
| 2015 |
Robinson AP, Rodgers JM, Goings GE, Miller SD. Characterizing oligodendroglial populations in development and disease using flow cytometry. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 47: 51-2. PMID 26531467 DOI: 10.1016/J.Ijdevneu.2015.04.145 |
0.591 |
|
| 2015 |
Hlavaty KA, McCarthy DP, Saito E, Yap WT, Miller SD, Shea LD. Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation. Biomaterials. 76: 1-10. PMID 26513216 DOI: 10.1016/J.Biomaterials.2015.10.041 |
0.661 |
|
| 2015 |
Lawson BR, Gonzalez-Quintial R, Eleftheriadis T, Farrar MA, Miller SD, Sauer K, McGavern DB, Kono DH, Baccala R, Theofilopoulos AN. Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation. Clinical Immunology (Orlando, Fla.). 161: 260-269. PMID 26319414 DOI: 10.1016/J.Clim.2015.08.007 |
0.303 |
|
| 2015 |
Chastain EM, Getts DR, Miller SD. Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler's Virus-Induced Autoimmunity. Mbio. 6: e01175. PMID 26242630 DOI: 10.1128/mBio.01175-15 |
0.389 |
|
| 2015 |
McCarthy DP, Bryant J, Galvin JP, Miller SD, Luo X. Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 1475-83. PMID 25807873 DOI: 10.1111/Ajt.13237 |
0.664 |
|
| 2015 |
Rodgers JM, Robinson AP, Rosler ES, Lariosa-Willingham K, Persons RE, Dugas JC, Miller SD. IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells. Glia. 63: 768-79. PMID 25557204 DOI: 10.1002/Glia.22783 |
0.596 |
|
| 2015 |
Smarr CB, Getts DR, Miller SD. Therapeutic Immune Tolerance Approaches for the Treatment of Allergic Disease Translational Immunology: Mechanisms and Pharmacologic Approaches. 259-284. DOI: 10.1016/B978-0-12-801577-3.00011-3 |
0.8 |
|
| 2014 |
Goldner JS, Quimby D, Richards MH, Zakaryan A, Miller S, Dickson D, Chilson J. Relations of Parenting to Adolescent Externalizing and Internalizing Distress Moderated by Perception of Neighborhood Danger. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 1-14. PMID 25425100 DOI: 10.1080/15374416.2014.958838 |
0.481 |
|
| 2014 |
Robinson AP, Rodgers JM, Goings GE, Miller SD. Characterization of oligodendroglial populations in mouse demyelinating disease using flow cytometry: clues for MS pathogenesis. Plos One. 9: e107649. PMID 25247590 DOI: 10.1371/Journal.Pone.0107649 |
0.706 |
|
| 2014 |
Sarraj B, Ye J, Akl AI, Chen G, Wang JJ, Zhang Z, Abadja F, Abecassis M, Miller SD, Kansas GS, Ansari MJ. Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection. Proceedings of the National Academy of Sciences of the United States of America. 111: 12145-50. PMID 25092331 DOI: 10.1073/Pnas.1303676111 |
0.337 |
|
| 2014 |
Blink SE, Caldis MW, Goings GE, Harp CT, Malissen B, Prinz I, Xu D, Miller SD. γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis. Cellular Immunology. 290: 39-51. PMID 24860937 DOI: 10.1016/j.cellimm.2014.04.013 |
0.39 |
|
| 2014 |
Flechner SM, Mulgoankar S, Melton LB, Waid TH, Agarwal A, Miller SD, Fokta F, Getts MT, Frederick TJ, Herrman JJ, Puisis JP, O'Toole L, Sung R, Shihab F, Wiseman AC, et al. First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 14: 1346-55. PMID 24751150 DOI: 10.1111/ajt.12698 |
0.743 |
|
| 2014 |
McCarthy DP, Hunter ZN, Chackerian B, Shea LD, Miller SD. Targeted immunomodulation using antigen-conjugated nanoparticles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 6: 298-315. PMID 24616452 DOI: 10.1002/Wnan.1263 |
0.642 |
|
| 2014 |
Hunter Z, McCarthy DP, Yap WT, Harp CT, Getts DR, Shea LD, Miller SD. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. Acs Nano. 8: 2148-60. PMID 24559284 DOI: 10.1021/Nn405033R |
0.742 |
|
| 2014 |
Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handbook of Clinical Neurology. 122: 173-89. PMID 24507518 DOI: 10.1016/B978-0-444-52001-2.00008-X |
0.302 |
|
| 2014 |
Getts DR, Terry RL, Getts MT, Deffrasnes C, Müller M, van Vreden C, Ashhurst TM, Chami B, McCarthy D, Wu H, Ma J, Martin A, Shae LD, Witting P, Kansas GS, ... ... Miller SD, et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Science Translational Medicine. 6: 219ra7. PMID 24431111 DOI: 10.1126/Scitranslmed.3007563 |
0.808 |
|
| 2014 |
Robinson AP, Rodgers JM, Goings GE, Miller SD. Characterizing oligodendrocyte lineage cell function by flow cytometry in animal models of demyelination Journal of Neuroimmunology. 275: 187-188. DOI: 10.1016/J.Jneuroim.2014.08.505 |
0.613 |
|
| 2013 |
Getts DR, McCarthy DP, Miller SD. Exploiting apoptosis for therapeutic tolerance induction. Journal of Immunology (Baltimore, Md. : 1950). 191: 5341-6. PMID 24244028 DOI: 10.4049/Jimmunol.1302070 |
0.7 |
|
| 2013 |
Smarr CB, Bryce PJ, Miller SD. Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Critical Reviews in Immunology. 33: 389-414. PMID 24099300 DOI: 10.1615/Critrevimmunol.2013007046 |
0.821 |
|
| 2013 |
Getts DR, Chastain EM, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunological Reviews. 255: 197-209. PMID 23947356 DOI: 10.1111/imr.12091 |
0.359 |
|
| 2013 |
Rodgers JM, Robinson AP, Miller SD. Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis. Discovery Medicine. 16: 53-63. PMID 23911232 |
0.668 |
|
| 2013 |
Podojil JR, Liu LN, Marshall SA, Chiang MY, Goings GE, Chen L, Langermann S, Miller SD. B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms. Journal of Autoimmunity. 44: 71-81. PMID 23683881 DOI: 10.1016/J.Jaut.2013.04.001 |
0.354 |
|
| 2013 |
Robinson AP, Caldis MW, Harp CT, Goings GE, Miller SD. High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis. Journal of Autoimmunity. 43: 32-43. PMID 23514872 DOI: 10.1016/j.jaut.2013.02.005 |
0.398 |
|
| 2013 |
Podojil JR, Miller SD. Targeting the B7 family of co-stimulatory molecules: successes and challenges. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 27: 1-13. PMID 23329394 DOI: 10.1007/s40259-012-0001-6 |
0.377 |
|
| 2013 |
Graham ML, Hennessy EA, Wang S, Martins KV, Suarez-Pinzon WL, Bansal-Pakala P, Flanagan BF, Murtaugh MP, Azimzadeh AM, Hancock WH, Miller SD, Luo X, Hering BJ. The immunobiology of pig-to-nonhuman primate islet xenotransplantation: insights, innovation, and impact Xenotransplantation. 20: 50-50. DOI: 10.1111/Xen.12014_8 |
0.352 |
|
| 2013 |
Getts DR, Getts MT, King NJC, Miller SD. Infectious Triggers of T Cell Autoimmunity The Autoimmune Diseases: Fifth Edition. 263-274. DOI: 10.1016/B978-0-12-384929-8.00019-8 |
0.774 |
|
| 2012 |
Prasad S, Xu D, Miller SD. Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes. The Review of Diabetic Studies : Rds. 9: 319-27. PMID 23804269 DOI: 10.1900/RDS.2012.9.319 |
0.352 |
|
| 2012 |
Rodgers JM, Miller SD. Cytokine control of inflammation and repair in the pathology of multiple sclerosis. The Yale Journal of Biology and Medicine. 85: 447-68. PMID 23239947 |
0.718 |
|
| 2012 |
Getts DR, Martin AJ, McCarthy DP, Terry RL, Hunter ZN, Yap WT, Getts MT, Pleiss M, Luo X, King NJ, Shea LD, Miller SD. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nature Biotechnology. 30: 1217-24. PMID 23159881 DOI: 10.1038/Nbt.2434 |
0.83 |
|
| 2012 |
McCarthy DP, Richards MH, Miller SD. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods in Molecular Biology (Clifton, N.J.). 900: 381-401. PMID 22933080 DOI: 10.1007/978-1-60761-720-4_19 |
0.784 |
|
| 2012 |
Prasad S, Kohm AP, McMahon JS, Luo X, Miller SD. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. Journal of Autoimmunity. 39: 347-53. PMID 22647732 DOI: 10.1016/j.jaut.2012.04.005 |
0.339 |
|
| 2012 |
Chang RA, Miller SD, Longnecker R. Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function. Scientific Reports. 2: 353. PMID 22616025 DOI: 10.1038/Srep00353 |
0.351 |
|
| 2012 |
Chastain EM, Miller SD. Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunological Reviews. 245: 227-38. PMID 22168423 DOI: 10.1111/j.1600-065X.2011.01076.x |
0.349 |
|
| 2012 |
Hsu C, Smarr C, Byrne A, Miller S, Bryce P. Rapid Induction of Tolerance To Peanut By Antigen-coupled Cell Transfer Journal of Allergy and Clinical Immunology. 129: AB1. DOI: 10.1016/J.Jaci.2011.12.863 |
0.787 |
|
| 2012 |
Eagar TN, Miller SD. Helper T-cell subsets and control of the inflammatory response Clinical Immunology: Principles and Practice: Fourth Edition. 203-214. DOI: 10.1016/B978-0-7234-3691-1.00014-3 |
0.652 |
|
| 2011 |
Smarr CB, Hsu CL, Byrne AJ, Miller SD, Bryce PJ. Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy. Journal of Immunology (Baltimore, Md. : 1950). 187: 5090-8. PMID 21976774 DOI: 10.4049/Jimmunol.1100608 |
0.809 |
|
| 2011 |
Getts DR, Turley DM, Smith CE, Harp CT, McCarthy D, Feeney EM, Getts MT, Martin AJ, Luo X, Terry RL, King NJ, Miller SD. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 2405-17. PMID 21821796 DOI: 10.4049/Jimmunol.1004175 |
0.802 |
|
| 2011 |
Getts DR, Shankar S, Chastain EM, Martin A, Getts MT, Wood K, Miller SD. Current landscape for T-cell targeting in autoimmunity and transplantation. Immunotherapy. 3: 853-70. PMID 21751954 DOI: 10.2217/Imt.11.61 |
0.76 |
|
| 2011 |
Podojil JR, Padval MV, Miller SD. Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis. Cellular Immunology. 270: 237-50. PMID 21696712 DOI: 10.1016/j.cellimm.2011.05.015 |
0.375 |
|
| 2011 |
Duncan DS, Miller SD. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease. Plos One. 6: e18548. PMID 21494618 DOI: 10.1371/Journal.Pone.0018548 |
0.765 |
|
| 2011 |
Richards MH, Getts MT, Podojil JR, Jin YH, Kim BS, Miller SD. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. Journal of Autoimmunity. 36: 142-54. PMID 21273044 DOI: 10.1016/J.Jaut.2010.12.005 |
0.843 |
|
| 2011 |
Dogan RN, Long N, Forde E, Dennis K, Kohm AP, Miller SD, Karpus WJ. CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function. Journal of Leukocyte Biology. 89: 93-104. PMID 20940325 DOI: 10.1189/Jlb.0810442 |
0.38 |
|
| 2011 |
Chastain EM, Duncan DS, Rodgers JM, Miller SD. The role of antigen presenting cells in multiple sclerosis. Biochimica Et Biophysica Acta. 1812: 265-74. PMID 20637861 DOI: 10.1016/J.Bbadis.2010.07.008 |
0.835 |
|
| 2010 |
Getts DR, Getts MT, McCarthy DP, Chastain EM, Miller SD. Have we overestimated the benefit of human(ized) antibodies? Mabs. 2: 682-94. PMID 20935511 DOI: 10.4161/Mabs.2.6.13601 |
0.769 |
|
| 2010 |
Martin AJ, McCarthy D, Waltenbaugh C, Goings G, Luo X, Miller SD. Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation. Journal of Immunology (Baltimore, Md. : 1950). 185: 3326-36. PMID 20713889 DOI: 10.4049/Jimmunol.1000802 |
0.666 |
|
| 2010 |
Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, Huang M, Schneider M, Miller SD, Ting JP. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. Journal of Immunology (Baltimore, Md. : 1950). 185: 974-81. PMID 20574004 DOI: 10.4049/Jimmunol.0904145 |
0.312 |
|
| 2010 |
Jin YH, Hou W, Kim SJ, Fuller AC, Kang B, Goings G, Miller SD, Kim BS. Type I interferon signals control Theiler's virus infection site, cellular infiltration and T cell stimulation in the CNS. Journal of Neuroimmunology. 226: 27-37. PMID 20538350 DOI: 10.1016/j.jneuroim.2010.05.028 |
0.351 |
|
| 2010 |
Zhang H, Podojil JR, Chang J, Luo X, Miller SD. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 184: 6629-36. PMID 20483764 DOI: 10.4049/jimmunol.0904044 |
0.392 |
|
| 2010 |
Getts MT, Miller SD. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections. Clinical and Experimental Immunology. 160: 15-21. PMID 20415846 DOI: 10.1111/j.1365-2249.2010.04132.x |
0.769 |
|
| 2010 |
Getts MT, Richards MH, Miller SD. A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice. Virology. 402: 102-11. PMID 20381109 DOI: 10.1016/J.Virol.2010.02.031 |
0.845 |
|
| 2010 |
Rodgers JM, Zhou L, Miller SD. Act1, scene brain: astrocytes play a lead role. Immunity. 32: 302-4. PMID 20346771 DOI: 10.1016/J.Immuni.2010.03.009 |
0.607 |
|
| 2010 |
Turley DM, Miller SD. Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis. Results and Problems in Cell Differentiation. 51: 217-35. PMID 19130025 DOI: 10.1007/400_2008_13 |
0.751 |
|
| 2010 |
Miller S, Caldis M, Polakow SB. CNS-infiltrating Vγ4+ γδ T Cells Produce High Levels of IL-17 and Appear to Contribute Significantly to the Pathogenesis of the SJL Relapsing EAE Model of Multiple Sclerosis Clinical Immunology. 135: S134. DOI: 10.1016/J.Clim.2010.03.405 |
0.396 |
|
| 2010 |
Martin A, McCarthy D, Miller S. Ethylenecarbodiimide-treated Splenocytes Carrying Male CD4 Epitopes Confer Hya Transplant Tolerance by Interfering with CD40/CD154 Signals Clinical Immunology. 135: S50. DOI: 10.1016/J.Clim.2010.03.152 |
0.658 |
|
| 2009 |
Podojil JR, Miller SD. Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy. Immunological Reviews. 229: 337-55. PMID 19426232 DOI: 10.1111/j.1600-065X.2009.00773.x |
0.397 |
|
| 2009 |
Olson JK, Miller SD. The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease. Journal of Immunology (Baltimore, Md. : 1950). 182: 5712-22. PMID 19380818 DOI: 10.4049/jimmunol.0801940 |
0.427 |
|
| 2009 |
Münz C, Lünemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nature Reviews. Immunology. 9: 246-58. PMID 19319143 DOI: 10.1038/Nri2527 |
0.77 |
|
| 2009 |
Blink SE, Miller SD. The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Current Molecular Medicine. 9: 15-22. PMID 19199938 DOI: 10.2174/156652409787314516 |
0.333 |
|
| 2009 |
Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 57: 1192-203. PMID 19191336 DOI: 10.1002/Glia.20841 |
0.354 |
|
| 2009 |
Zhang H, Podojil J, Miller S. OR.103. Induced PLP Peptide-specific Regulatory T Cells Appear to Suppress Experimental Autoimmune Encephalomyelitis in an Antigen-specific Manner Clinical Immunology. 131: S42. DOI: 10.1016/J.Clim.2009.03.118 |
0.434 |
|
| 2008 |
Getts MT, Getts DR, Kohm AP, Miller SD. Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis. Therapy (London, England : 2004). 5: 631-640. PMID 20357912 DOI: 10.2217/14750708.5.5.631 |
0.753 |
|
| 2008 |
Podojil JR, Turley DM, Miller SD. Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease. Advances in Experimental Medicine and Biology. 640: 234-51. PMID 19065796 DOI: 10.1007/978-0-387-09789-3_18 |
0.75 |
|
| 2008 |
Greene MT, Ercolini AM, DeGutes M, Miller SD. Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor. Journal of Autoimmunity. 31: 399-407. PMID 19008075 DOI: 10.1016/j.jaut.2008.09.004 |
0.425 |
|
| 2008 |
Edlynn ES, Gaylord-Harden NK, Richards MH, Miller SA. African American inner-city youth exposed to violence: coping skills as a moderator for anxiety. The American Journal of Orthopsychiatry. 78: 249-58. PMID 18954188 DOI: 10.1037/A0013948 |
0.483 |
|
| 2008 |
Zhang H, Podojil JR, Luo X, Miller SD. Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 181: 4638-47. PMID 18802066 |
0.37 |
|
| 2008 |
Luo X, Pothoven KL, McCarthy D, DeGutes M, Martin A, Getts DR, Xia G, He J, Zhang X, Kaufman DB, Miller SD. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proceedings of the National Academy of Sciences of the United States of America. 105: 14527-32. PMID 18796615 DOI: 10.1073/Pnas.0805204105 |
0.662 |
|
| 2008 |
Cannon JL, Collins A, Mody PD, Balachandran D, Henriksen KJ, Smith CE, Tong J, Clay BS, Miller SD, Sperling AI. CD43 regulates Th2 differentiation and inflammation. Journal of Immunology (Baltimore, Md. : 1950). 180: 7385-93. PMID 18490738 DOI: 10.4049/Jimmunol.180.11.7385 |
0.71 |
|
| 2008 |
Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JA, Dzionek A, Miller SD. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 180: 6457-61. PMID 18453561 DOI: 10.4049/jimmunol.180.10.6457 |
0.387 |
|
| 2008 |
Carpentier PA, Getts MT, Miller SD. Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease. Virology. 375: 24-36. PMID 18289626 DOI: 10.1016/J.Virol.2008.01.024 |
0.831 |
|
| 2008 |
Carpentier PA, Duncan DS, Miller SD. Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain, Behavior, and Immunity. 22: 140-7. PMID 17920811 DOI: 10.1016/J.Bbi.2007.08.011 |
0.813 |
|
| 2008 |
Miller S, Kohm A, Prasad S, Turley D, McCarthy D, Luo X. OR.19. An Antigen-specific Approach to the Treatment of Type 1 Diabetes and Islet Transplantation Clinical Immunology. 127. DOI: 10.1016/J.Clim.2008.03.024 |
0.764 |
|
| 2008 |
Carpentier PA, Duncan DS, Miller SD. Pattern recognition receptors in CNS disease Central Nervous System Diseases and Inflammation. 131-152. DOI: 10.1007/978-0-387-73894-9_7 |
0.793 |
|
| 2007 |
Ercolini AM, Miller SD. Molecular mimics can induce novel self peptide-reactive CD4+ T cell clonotypes in autoimmune disease. Journal of Immunology (Baltimore, Md. : 1950). 179: 6604-12. PMID 17982050 DOI: 10.4049/jimmunol.179.10.6604 |
0.333 |
|
| 2007 |
Chung DT, Korn T, Richard J, Ruzek M, Kohm AP, Miller S, Nahill S, Oukka M. Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expanding myelin antigen-specific Foxp3+ regulatory T cells. International Immunology. 19: 1003-10. PMID 17698561 DOI: 10.1093/Intimm/Dxm078 |
0.497 |
|
| 2007 |
Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nature Reviews. Immunology. 7: 665-77. PMID 17690713 DOI: 10.1038/Nri2153 |
0.709 |
|
| 2007 |
Getts MT, Kim BS, Miller SD. Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells. Journal of Virology. 81: 6584-93. PMID 17428853 DOI: 10.1128/Jvi.00008-07 |
0.81 |
|
| 2007 |
Bennett JL, Elhofy A, Charo I, Miller SD, Dal Canto MC, Karpus WJ. CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Viral Immunology. 20: 19-33. PMID 17425418 DOI: 10.1089/Vim.2006.0068 |
0.427 |
|
| 2007 |
Miller SD, McMahon EJ, Schreiner B, Bailey SL. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Annals of the New York Academy of Sciences. 1103: 179-91. PMID 17376826 DOI: 10.1196/annals.1394.023 |
0.435 |
|
| 2007 |
Ercolini AM, Ludovic Croxford J, Degutes M, Miller SD. Cross-reactivity between peptide mimics of the immunodominant myelin proteolipid protein epitope PLP139-151: comparison of peptide priming in CFA vs. viral delivery. Journal of Neuroimmunology. 186: 5-18. PMID 17376542 DOI: 10.1016/j.jneuroim.2007.02.002 |
0.357 |
|
| 2007 |
Turley DM, Miller SD. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 178: 2212-20. PMID 17277126 DOI: 10.4049/Jimmunol.178.4.2212 |
0.725 |
|
| 2007 |
Bailey SL, Schreiner B, McMahon EJ, Miller SD. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE Nature Immunology. 8: 172-180. PMID 17206145 DOI: 10.1038/ni1430 |
0.321 |
|
| 2007 |
Carpentier PA, Williams BR, Miller SD. Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia. 55: 239-52. PMID 17091495 DOI: 10.1002/Glia.20450 |
0.798 |
|
| 2007 |
Miller S, Bailey S, Schreiner B. CNS Myeloid Dendritic Cells Drive Epitope Spreading and Th-17 Differentiation in Relapsing Experimental Autoimmune Encephalomyelitis (R-EAE) Clinical Immunology. 123: S61. DOI: 10.1016/J.Clim.2007.03.352 |
0.386 |
|
| 2007 |
Chung D, Korn T, Richard J, Kohm A, Ruzek M, Oukka M, Miller S, Nahill S, Kuchroo V. Anti-Thymocyte Globulin Prevents Autoimmune Encephalomyelitis by Expanding Myelin Antigen Specific Foxp3+ Regulatory T Cells Clinical Immunology. 123. DOI: 10.1016/J.Clim.2007.03.200 |
0.472 |
|
| 2006 |
Smith CE, Miller SD. Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities. Journal of Autoimmunity. 27: 218-31. PMID 17289470 DOI: 10.1016/J.Jaut.2006.12.002 |
0.692 |
|
| 2006 |
Croxford JL, Ercolini AM, Degutes M, Miller SD. Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus. European Journal of Immunology. 36: 2671-80. PMID 16981179 DOI: 10.1002/eji.200635876 |
0.325 |
|
| 2006 |
Podojil JR, Kohm AP, Miller SD. CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 177: 2948-58. PMID 16920930 DOI: 10.4049/jimmunol.177.5.2948 |
0.365 |
|
| 2006 |
McMahon EJ, Bailey SL, Miller SD. CNS dendritic cells: Critical participants in CNS inflammation? Neurochemistry International. 49: 195-203. PMID 16730862 DOI: 10.1016/j.neuint.2006.04.004 |
0.357 |
|
| 2006 |
Bailey SL, Carpentier PA, McMahon EJ, Begolka WS, Miller SD. Innate and adaptive immune responses of the central nervous system. Critical Reviews in Immunology. 26: 149-88. PMID 16700651 DOI: 10.1615/Critrevimmunol.V26.I2.40 |
0.804 |
|
| 2005 |
Kohm AP, Turley DM, Miller SD. Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease. International Reviews of Immunology. 24: 361-92. PMID 16318987 DOI: 10.1080/08830180500371207 |
0.745 |
|
| 2005 |
Minter LM, Turley DM, Das P, Shin HM, Joshi I, Lawlor RG, Cho OH, Palaga T, Gottipati S, Telfer JC, Kostura L, Fauq AH, Simpson K, Such KA, Miele L, ... ... Miller SD, et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nature Immunology. 6: 680-8. PMID 15991363 DOI: 10.1038/Ni1209X |
0.724 |
|
| 2005 |
Smith CE, Eagar TN, Strominger JL, Miller SD. Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 102: 9595-600. PMID 15983366 DOI: 10.1073/Pnas.0504131102 |
0.767 |
|
| 2005 |
Croxford JL, Olson JK, Anger HA, Miller SD. Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis. Journal of Virology. 79: 8581-90. PMID 15956599 DOI: 10.1128/JVI.79.13.8581-8590.2005 |
0.33 |
|
| 2005 |
Howard LM, Kohm AP, Castaneda CL, Miller SD. Therapeutic blockade of TCR signal transduction and co-stimulation in autoimmune disease. Current Drug Targets. Inflammation and Allergy. 4: 205-16. PMID 15853743 DOI: 10.2174/1568010053586228 |
0.358 |
|
| 2005 |
Kohm AP, Williams JS, Bickford AL, McMahon JS, Chatenoud L, Bach JF, Bluestone JA, Miller SD. Treatment with Nonmitogenic Anti-CD3 Monoclonal Antibody Induces CD4+ T Cell Unresponsiveness and Functional Reversal of Established Experimental Autoimmune Encephalomyelitis Journal of Immunology. 174: 4525-4534. PMID 15814673 DOI: 10.4049/Jimmunol.174.8.4525 |
0.365 |
|
| 2005 |
McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis Nature Medicine. 11: 335-339. PMID 15735651 DOI: 10.1038/nm1202 |
0.393 |
|
| 2005 |
Croxford JL, Anger HA, Miller SD. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry. Journal of Immunology (Baltimore, Md. : 1950). 174: 907-17. PMID 15634913 DOI: 10.4049/jimmunol.174.2.907 |
0.436 |
|
| 2005 |
Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia. 49: 360-74. PMID 15538753 DOI: 10.1002/Glia.20117 |
0.789 |
|
| 2005 |
Olson JK, Miller SD. The role of T cells and the innate immune system in the pathogenesis of theiler's virus demyeliating disease Experimental Models of Multiple Sclerosis. 645-657. DOI: 10.1007/0-387-25518-4_32 |
0.364 |
|
| 2004 |
Christen U, Edelmann KH, McGavern DB, Wolfe T, Coon B, Teague MK, Miller SD, Oldstone MB, von Herrath MG. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. The Journal of Clinical Investigation. 114: 1290-8. PMID 15520861 DOI: 10.1172/Jci22557 |
0.306 |
|
| 2004 |
Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. Journal of Immunology (Baltimore, Md. : 1950). 173: 3916-24. PMID 15356140 DOI: 10.4049/jimmunol.173.6.3916 |
0.317 |
|
| 2004 |
Fuller KG, Olson JK, Howard LM, Croxford JL, Miller SD. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods in Molecular Medicine. 102: 339-61. PMID 15286394 DOI: 10.1385/1-59259-805-6:339 |
0.34 |
|
| 2004 |
Eagar TN, Turley DM, Padilla J, Karandikar NJ, Tan L, Bluestone JA, Miller SD. CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance. Journal of Immunology (Baltimore, Md. : 1950). 172: 7442-50. PMID 15187122 DOI: 10.4049/Jimmunol.172.12.7442 |
0.801 |
|
| 2004 |
Mack CL, Tucker RM, Sokol RJ, Karrer FM, Kotzin BL, Whitington PF, Miller SD. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatric Research. 56: 79-87. PMID 15128911 DOI: 10.1203/01.Pdr.0000130480.51066.Fb |
0.32 |
|
| 2004 |
Kohm AP, Williams JS, Miller SD. Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 172: 4686-90. PMID 15067043 DOI: 10.4049/jimmunol.172.8.4686 |
0.373 |
|
| 2004 |
Olson JK, Ludovic Croxford J, Miller SD. Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry. Molecular Immunology. 40: 1103-8. PMID 15036915 DOI: 10.1016/j.molimm.2003.11.010 |
0.421 |
|
| 2003 |
Kohm AP, Carpentier PA, Miller SD. Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+ regulatory T cells. Novartis Foundation Symposium. 252: 45-52; discussion 52. PMID 14609211 DOI: 10.1002/0470871628.Ch4 |
0.821 |
|
| 2003 |
Mack CL, Vanderlugt-Castaneda CL, Neville KL, Miller SD. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis. Journal of Neuroimmunology. 144: 68-79. PMID 14597100 DOI: 10.1016/J.Jneuroim.2003.08.032 |
0.79 |
|
| 2003 |
Olson JK, Zamvil SS, Miller SD. Efficient technique for immortalization of murine microglial cells relevant for studies in murine models of multiple sclerosis. Journal of Neuroscience Methods. 128: 33-43. PMID 12948546 DOI: 10.1016/S0165-0270(03)00145-6 |
0.404 |
|
| 2003 |
Theien BE, Vanderlugt CL, Nickerson-Nutter C, Cornebise M, Scott DM, Perper SJ, Whalley ET, Miller SD. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE. Blood. 102: 4464-71. PMID 12933585 DOI: 10.1182/blood-2003-03-0974 |
0.355 |
|
| 2003 |
Croxford JL, Miller SD. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212. The Journal of Clinical Investigation. 111: 1231-40. PMID 12697742 DOI: 10.1172/JCI17652 |
0.304 |
|
| 2003 |
Howard LM, Neville KL, Haynes LM, Dal Canto MC, Miller SD. CD154 blockade results in transient reduction in Theiler's murine encephalomyelitis virus-induced demyelinating disease. Journal of Virology. 77: 2247-50. PMID 12525660 DOI: 10.1128/Jvi.77.3.2247-2250.2003 |
0.78 |
|
| 2002 |
Croxford JL, Olson JK, Miller SD. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmunity Reviews. 1: 251-60. PMID 12848977 DOI: 10.1016/S1568-9972(02)00080-0 |
0.365 |
|
| 2002 |
Kohm AP, Carpentier PA, Anger HA, Miller SD. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 169: 4712-6. PMID 12391178 DOI: 10.4049/Jimmunol.169.9.4712 |
0.824 |
|
| 2002 |
Olson JK, Eagar TN, Miller SD. Functional activation of myelin-specific T cells by virus-induced molecular mimicry. Journal of Immunology (Baltimore, Md. : 1950). 169: 2719-26. PMID 12193746 DOI: 10.4049/Jimmunol.169.5.2719 |
0.732 |
|
| 2002 |
Howard LM, Dal Canto MC, Miller SD. Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses. Journal of Neuroimmunology. 129: 58-65. PMID 12161021 DOI: 10.1016/S0165-5728(02)00175-3 |
0.368 |
|
| 2002 |
Girvin AM, Gordon KB, Welsh CJ, Clipstone NA, Miller SD. Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. Blood. 99: 3692-701. PMID 11986225 DOI: 10.1182/Blood-2001-12-0229 |
0.814 |
|
| 2002 |
Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 168: 4173-83. PMID 11937578 |
0.317 |
|
| 2002 |
Eagar TN, Karandikar NJ, Bluestone JA, Miller SD. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. European Journal of Immunology. 32: 972-81. PMID 11920563 DOI: 10.1002/1521-4141(200204)32:4<972::Aid-Immu972>3.0.Co;2-M |
0.713 |
|
| 2002 |
Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nature Reviews. Immunology. 2: 85-95. PMID 11910899 DOI: 10.1038/nri724 |
0.386 |
|
| 2002 |
Girvin AM, Dal Canto MC, Miller SD. CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated co-stimulation. Journal of Autoimmunity. 18: 83-94. PMID 11908941 DOI: 10.1006/Jaut.2001.0573 |
0.813 |
|
| 2002 |
Neville KL, Padilla J, Miller SD. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS. Journal of Neuroimmunology. 123: 18-29. PMID 11880145 DOI: 10.1016/S0165-5728(01)00479-9 |
0.798 |
|
| 2002 |
Howard LM, Ostrovidov S, Smith CE, Dal Canto MC, Miller SD. Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 109: 233-41. PMID 11805135 DOI: 10.1172/Jci14374 |
0.711 |
|
| 2001 |
Begolka WS, Haynes LM, Olson JK, Padilla J, Neville KL, Dal Canto M, Palma J, Kim BS, Miller SD. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. Journal of Neurovirology. 7: 409-20. PMID 11582513 DOI: 10.1080/135502801753170264 |
0.79 |
|
| 2001 |
Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunology. 14: 227-50. PMID 11572634 DOI: 10.1089/088282401753266756 |
0.318 |
|
| 2001 |
Olson JK, Girvin AM, Miller SD. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. Journal of Virology. 75: 9780-9. PMID 11559811 DOI: 10.1128/Jvi.75.20.9780-9789.2001 |
0.835 |
|
| 2001 |
Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, Arcella J, Girvin AM, Padilla J, Miller SD, Bluestone JA. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. The Journal of Experimental Medicine. 194: 677-84. PMID 11535635 DOI: 10.1084/Jem.194.5.677 |
0.825 |
|
| 2001 |
Miller SD, Eagar TN. Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases. Advances in Experimental Medicine and Biology. 490: 99-107. PMID 11505979 DOI: 10.1007/978-1-4615-1243-1_10 |
0.736 |
|
| 2001 |
Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD. A virus-induced molecular mimicry model of multiple sclerosis. The Journal of Clinical Investigation. 108: 311-8. PMID 11457884 DOI: 10.1172/JCI13032 |
0.409 |
|
| 2001 |
Miller SD, Katz-Levy Y, Neville KL, Vanderlugt CL. Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system. Advances in Virus Research. 56: 199-217. PMID 11450300 DOI: 10.1016/S0065-3527(01)56008-X |
0.765 |
|
| 2001 |
Theien BE, Vanderlugt CL, Eagar TN, Nickerson-Nutter C, Nazareno R, Kuchroo VK, Miller SD. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 107: 995-1006. PMID 11306603 DOI: 10.1172/Jci11717 |
0.725 |
|
| 2001 |
Godsel LM, Wang K, Schodin BA, Leon JS, Miller SD, Engman DM. Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance. Circulation. 103: 1709-14. PMID 11274001 DOI: 10.1161/01.Cir.103.12.1709 |
0.361 |
|
| 2000 |
Suvannavejh GC, Lee HO, Padilla J, Dal Canto MC, Barrett TA, Miller SD. Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cellular Immunology. 205: 24-33. PMID 11078604 DOI: 10.1006/Cimm.2000.1706 |
0.797 |
|
| 2000 |
Katz-Levy Y, Neville KL, Padilla J, Rahbe S, Begolka WS, Girvin AM, Olson JK, Vanderlugt CL, Miller SD. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice. Journal of Immunology (Baltimore, Md. : 1950). 165: 5304-14. PMID 11046065 DOI: 10.4049/Jimmunol.165.9.5304 |
0.839 |
|
| 2000 |
Sabelko-Downes KA, Gimenez MT, Suvannavejh GC, Miller SD, Russell JH. Genetic control of pathogenic mechanisms in autoimmune demyelinating disease. Journal of Neuroimmunology. 110: 168-76. PMID 11024547 DOI: 10.1016/S0165-5728(00)00350-7 |
0.808 |
|
| 2000 |
Karandikar NJ, Eagar TN, Vanderlugt CL, Bluestone JA, Miller SD. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 109: 173-80. PMID 10996219 DOI: 10.1016/S0165-5728(00)00322-2 |
0.709 |
|
| 2000 |
Neville KL, Dal Canto MC, Bluestone JA, Miller SD. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease. Journal of Virology. 74: 8349-57. PMID 10954534 DOI: 10.1128/Jvi.74.18.8349-8357.2000 |
0.794 |
|
| 2000 |
Haynes LM, Vanderlugt CL, Dal Canto MC, Melvold RW, Miller SD. CD8(+) T cells from Theiler's virus-resistant BALB/cByJ mice downregulate pathogenic virus-specific CD4(+) T cells. Journal of Neuroimmunology. 106: 43-52. PMID 10814781 DOI: 10.1016/S0165-5728(00)00212-5 |
0.406 |
|
| 2000 |
Vanderlugt CL, Rahbe SM, Elliott PJ, Dal Canto MC, Miller SD. Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519. Journal of Autoimmunity. 14: 205-11. PMID 10756082 DOI: 10.1006/jaut.2000.0370 |
0.385 |
|
| 2000 |
Dal Canto MC, Calenoff MA, Miller SD, Vanderlugt CL. Lymphocytes from mice chronically infected with Theiler's murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein. Epitope spreading in TMEV infection has functional activity. Journal of Neuroimmunology. 104: 79-84. PMID 10683517 DOI: 10.1016/S0165-5728(99)00230-1 |
0.368 |
|
| 2000 |
Suvannavejh GC, Dal Canto MC, Matis LA, Miller SD. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 105: 223-31. PMID 10642601 DOI: 10.1172/JCI8561 |
0.817 |
|
| 2000 |
Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 164: 670-8. PMID 10623809 DOI: 10.4049/Jimmunol.164.2.670 |
0.845 |
|
| 2000 |
Girvin AM, Dal Canto MC, Rhee L, Salomon B, Sharpe A, Bluestone JA, Miller SD. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. Journal of Immunology (Baltimore, Md. : 1950). 164: 136-43. PMID 10605004 DOI: 10.4049/Jimmunol.164.1.136 |
0.826 |
|
| 1999 |
Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. The Journal of Clinical Investigation. 104: 599-610. PMID 10487774 DOI: 10.1172/Jci7292 |
0.839 |
|
| 1999 |
Nicholson SM, Haynes LM, Vanderlugt CL, Miller SD, Melvold RW. The role of protective CD8+ T cells in resistance of BALB/c mice to Theiler's murine encephalomyelitis virus-induced demyelinating disease: regulatory vs. lytic. Journal of Neuroimmunology. 98: 136-46. PMID 10430047 DOI: 10.1016/S0165-5728(99)00090-9 |
0.341 |
|
| 1999 |
Howard LM, Miga AJ, Vanderlugt CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. The Journal of Clinical Investigation. 103: 281-90. PMID 9916140 DOI: 10.1172/Jci5388 |
0.425 |
|
| 1999 |
Burt RK, Padilla J, Dal Canto MC, Miller SD. Viral Hyperinfection of the Central Nervous System and High Mortality After Hematopoietic Stem Cell Transplantation for Treatment of Theiler’s Murine Encephalomyelitis Virus-Induced Demyelinating Disease Blood. 94: 2915-2922. DOI: 10.1182/blood.V94.8.2915.420k42_2915_2922 |
0.364 |
|
| 1998 |
Vanderlugt CL, Begolka WS, Neville KL, Katz-Levy Y, Howard LM, Eagar TN, Bluestone JA, Miller SD. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunological Reviews. 164: 63-72. PMID 9795764 DOI: 10.1111/J.1600-065X.1998.Tb01208.X |
0.852 |
|
| 1998 |
Karandikar NJ, Vanderlugt CL, Bluestone JA, Miller SD. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease. Journal of Neuroimmunology. 89: 10-8. PMID 9726820 DOI: 10.1016/S0165-5728(98)00058-7 |
0.339 |
|
| 1998 |
Tan LJ, Vanderlugt CL, McRae BL, Miller SD. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion. Autoimmunity. 27: 13-28. PMID 9482204 DOI: 10.3109/08916939809008034 |
0.402 |
|
| 1998 |
Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, Wojnarowska F, Stevens SR, Chen M, Fairley JA, Woodley DT, Miller SD, Gordon KB. Epitope spreading: lessons from autoimmune skin diseases. The Journal of Investigative Dermatology. 110: 103-9. PMID 9457902 DOI: 10.1046/j.1523-1747.1998.00107.x |
0.341 |
|
| 1998 |
Burt RK, Padilla J, Begolka WS, Canto MCD, Miller SD. Effect of Disease Stage on Clinical Outcome After Syngeneic Bone Marrow Transplantation for Relapsing Experimental Autoimmune Encephalomyelitis Blood. 91: 2609-2616. DOI: 10.1182/blood.V91.7.2609.2609_2609_2616 |
0.312 |
|
| 1998 |
Pope JG, Vanderlugt CL, Rahbe SM, Lipton HL, Miller SD. Characterization of and Functional Antigen Presentation by Central Nervous System Mononuclear Cells from Mice Infected with Theiler’s Murine Encephalomyelitis Virus Journal of Virology. 72: 7762-7771. DOI: 10.1128/jvi.72.10.7762-7771.1998 |
0.341 |
|
| 1998 |
Eagar T, Karanolikar N, Tan L, Lee H, Barrett T, Bluestone J, Miller S. Tolerance in EAE: A central role for CTLA-4 Journal of Neuroimmunology. 90: 81. DOI: 10.1016/S0165-5728(98)91662-9 |
0.624 |
|
| 1998 |
Haynes L, Miller S, Melvold R. Immune-mediated mechanisms of resistance to TMEV-IDD: A regulatory role for CD8+ T cells Journal of Neuroimmunology. 90: 66. DOI: 10.1016/S0165-5728(98)91575-2 |
0.331 |
|
| 1998 |
Suvannavejh G, Miller S. A potential role for FAS (CP95/APO-1) int he recovery phase of experimental autoimmune encephalomyelitis Journal of Neuroimmunology. 90: 61. DOI: 10.1016/S0165-5728(98)91543-0 |
0.766 |
|
| 1998 |
Neville K, Bluestone J, Miller S. Interference with costimulation alters disease course in Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) Journal of Neuroimmunology. 90: 59. DOI: 10.1016/S0165-5728(98)91533-8 |
0.739 |
|
| 1998 |
Katz-Levy Y, Neville K, Vanderlugt C, Miller S. Epitope spreading a vital model of multiple sclerosis Journal of Neuroimmunology. 90: 35. DOI: 10.1016/S0165-5728(98)91386-8 |
0.701 |
|
| 1998 |
Girvin A, Gordon K, Tan L, Welsh J, Miller S. Expression of MHC class II and costimulatory molecules by endothelial cells of the blood brain barrier: Effect on antigen presentation Journal of Neuroimmunology. 90: 21. DOI: 10.1016/S0165-5728(98)91306-6 |
0.775 |
|
| 1998 |
Miller S, Vanderlugt C, Begolka W, Suvannavejh G, Howard L, Eager T. Pathogenesis of epitope spreading in relapsing EAE-intrinsic and induced regulation Journal of Neuroimmunology. 90: 8. DOI: 10.1016/S0165-5728(98)91239-5 |
0.8 |
|
| 1997 |
Vanderlugt CL, Karandikar NJ, Lenschow DJ, Dal Canto MC, Bluestone JA, Miller SD. Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE. Journal of Neuroimmunology. 79: 113-8. PMID 9394783 DOI: 10.1016/S0165-5728(97)00108-2 |
0.329 |
|
| 1997 |
Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nature Medicine. 3: 1133-6. PMID 9334726 DOI: 10.1038/Nm1097-1133 |
0.797 |
|
| 1997 |
Miller SD, Vanderlugt CL, Begolka WS, Pao W, Neville KL, Yauch RL, Kim BS. Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus. Journal of Neurovirology. 3: S62-5. PMID 9179798 |
0.742 |
|
| 1997 |
McRae BL, Karandikar NJ, Miller SD. Degenerate antigen recognition by CD4+ effector T cells in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 75: 156-62. PMID 9143249 DOI: 10.1016/S0165-5728(97)00014-3 |
0.358 |
|
| 1997 |
Vanderlugt CJ, Miller SD. Epitope spreading. Current Opinion in Immunology. 8: 831-6. PMID 8994863 DOI: 10.1016/S0952-7915(96)80012-4 |
0.427 |
|
| 1996 |
Vandenbark AA, Vainiene M, Ariail K, Miller SD, Offner H. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes Journal of Neuroscience Research. 45: 430-438. PMID 8872903 DOI: 10.1002/(Sici)1097-4547(19960815)45:4<430::Aid-Jnr12>3.0.Co;2-4 |
0.36 |
|
| 1996 |
Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA. CTLA-4: a negative regulator of autoimmune disease. The Journal of Experimental Medicine. 184: 783-8. PMID 8760834 DOI: 10.1084/jem.184.2.783 |
0.433 |
|
| 1995 |
McRae BL, Nikcevich KM, Karpus WJ, Hurst SD, Miller SD. Differential recognition of peptide analogs by naive verses activated PLP 139-151-specific CD4+ T cells. Journal of Neuroimmunology. 60: 17-28. PMID 7543908 DOI: 10.1016/0165-5728(95)00048-7 |
0.38 |
|
| 1995 |
McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 182: 75-85. PMID 7540658 DOI: 10.1084/jem.182.1.75 |
0.417 |
|
| 1995 |
Nicholson SM, Canto MD, Miller S, Melvold R. PASSIVELY TRANSFERRED CD8+ T CELLS ABE CAPABLE OF PROVIDING PROTECTION AGAINST TMEV-INDUCED DEMYEUNATION IN BALB/c MICE, Journal of Neuropathology and Experimental Neurology. 54: 465. DOI: 10.1097/00005072-199505000-00234 |
0.418 |
|
| 1994 |
Nicholson SM, Peterson JD, Miller SD, Wang K, Dal Canto MC, Melvold RW. BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. Journal of Neuroimmunology. 52: 19-24. PMID 8207118 DOI: 10.1016/0165-5728(94)90157-0 |
0.303 |
|
| 1994 |
Karpus WJ, Peterson JD, Miller SD. Anergy in vivo: down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses. International Immunology. 6: 721-30. PMID 8080842 DOI: 10.1093/Intimm/6.5.721 |
0.349 |
|
| 1994 |
Pullen LC, Miller SD, Dal Canto MC, Van der Meide PH, Kim BS. Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease. Journal of Neuroimmunology. 55: 143-52. PMID 7829664 DOI: 10.1016/0165-5728(94)90004-3 |
0.33 |
|
| 1994 |
Miller SD, Karpus WJ. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases Trends in Immunology. 15: 356-361. DOI: 10.1016/0167-5699(94)90173-2 |
0.456 |
|
| 1993 |
Peterson JD, Karpus WJ, Clatch RJ, Miller SD. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. European Journal of Immunology. 23: 46-55. PMID 8419186 DOI: 10.1002/Eji.1830230109 |
0.327 |
|
| 1993 |
Pullen LC, Miller SD, Dal Canto MC, Kim BS. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. European Journal of Immunology. 23: 2287-93. PMID 8370406 DOI: 10.1002/eji.1830230935 |
0.415 |
|
| 1993 |
Pelka A, Olsberg C, Miller S, Waltenbaugh C, Creighton TM, dal Canto MC, Melvold R. Effects of irradiation on development of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice. Cellular Immunology. 152: 440-55. PMID 8258150 DOI: 10.1006/Cimm.1993.1303 |
0.41 |
|
| 1992 |
McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. Journal of Neuroimmunology. 38: 229-40. PMID 1376328 DOI: 10.1016/0165-5728(92)90016-E |
0.413 |
|
| 1992 |
Pope L, Paterson PY, Miller SD. Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats. Journal of Neuroimmunology. 37: 177-89. PMID 1373153 DOI: 10.1016/0165-5728(92)90002-3 |
0.301 |
|
| 1992 |
Miller SD, Tan LJ, Pope L, Mcrae BL, Karpus WJ. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis International Reviews of Immunology. 9: 203-222. PMID 1285061 DOI: 10.3109/08830189209061791 |
0.381 |
|
| 1991 |
Miller SD, Tan LJ, Kennedy MK, Dal Canto MC. Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction. Annals of the New York Academy of Sciences. 636: 79-94. PMID 1724364 DOI: 10.1111/j.1749-6632.1991.tb33440.x |
0.32 |
|
| 1990 |
Miller SD, Gerety SJ, Kennedy MK, Peterson JD, Trotter JL, Tuohy VK, Waltenbaugh C, Dal Canto MC, Lipton HL. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. Journal of Neuroimmunology. 26: 9-23. PMID 1688446 DOI: 10.1016/0165-5728(90)90115-4 |
0.446 |
|
| 1989 |
Miller SD, Clatch RJ, Lipton HL. Fine specificity of T-cell-mediated immune responses of susceptible and resistant strains in Theiler's murine encephalomyelitis virus-induced demyelinating disease. Annals of the New York Academy of Sciences. 540: 674-7. PMID 2849914 DOI: 10.1111/j.1749-6632.1988.tb27209.x |
0.364 |
|
| 1988 |
Crane M, Miller S, Lipton H, Kim B. Increases in the immune responses to Theiler's murine encephalomyelitis virus after neonatal treatment with anti-T-cell receptor antibody. Annals of the New York Academy of Sciences. 540: 669-671. PMID 2849912 DOI: 10.1111/J.1749-6632.1988.Tb27207.X |
0.421 |
|
| 1987 |
Clatch RJ, Melvold RW, Dal Canto MC, Miller SD, Lipton HL. The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C. Journal of Neuroimmunology. 15: 121-35. PMID 3584435 DOI: 10.1016/0165-5728(87)90087-7 |
0.354 |
|
| 1987 |
Kennedy MK, Clatch RJ, Dal Canto MC, Trotter JL, Miller SD. Monoclonal antibody-induced inhibition of relapsing EAE in SJL/J mice correlates with inhibition of neuroantigen-specific cell-mediated immune responses. Journal of Neuroimmunology. 16: 345-64. PMID 2444626 DOI: 10.1016/0165-5728(87)90110-X |
0.32 |
|
| 1987 |
Miller SD, Clatch RJ, Lipton HL. Fine specificity of T cell-mediated immune(CMI) responses of susceptible and resistant strains in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease Journal of Neuroimmunology. 16: 125-126. DOI: 10.1016/0165-5728(87)90322-5 |
0.365 |
|
| 1987 |
Crane M, Miller S, Lipton H, Kim B. Increase in the immune response against theiler's murine encephalomyelitis virus in balb/c mice after neonatal treatment with monoclonal antibodies specific for VB8 T cell antigen receptor Journal of Neuroimmunology. 16: 39. DOI: 10.1016/0165-5728(87)90186-X |
0.436 |
|
| 1985 |
Miller SD, Jenkins MK. In vivo effects of GK1.5 (anti-L3T4a) monoclonal antibody on induction and expression of delayed-type hypersensitivity Cellular Immunology. 92: 414-426. PMID 2859929 DOI: 10.1016/0008-8749(85)90022-X |
0.334 |
|
| 1984 |
Miller SD, Butler LD. T-Cell responses induced by the parenteral injection of antigen-modified syngeneic cells. III. Dissociation of primed cytolytic T-cell and efferent suppressor-T-cell activity following intravenous injection of trinitrophenol-modified syngeneic spleen cells Cellular Immunology. 86: 308-316. PMID 6234068 DOI: 10.1016/0008-8749(84)90385-X |
0.359 |
|
| 1984 |
Jenkins MK, Lei HY, Waltenbaugh C, Miller SD. Immunoregulatory pathways in adult responder mice. I. Induction of GAT-specific tolerance and suppressor T cells for cellular and humoral responses Scandinavian Journal of Immunology. 19: 501-512. PMID 6204374 DOI: 10.1111/J.1365-3083.1984.Tb00961.X |
0.335 |
|
| 1979 |
Sy MS, Miller SD, Moorhead JW, Claman HN. Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. The Journal of Experimental Medicine. 149: 1197-207. PMID 87487 DOI: 10.1084/jem.149.5.1197 |
0.314 |
|
| Show low-probability matches. |